Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 36.4218.0322.34159.317.95

What is the latest EV/Core EBITDA ratio of ORCHID PHARMA ?

The latest EV/Core EBITDA ratio of ORCHID PHARMA is 36.42 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202436.42
Mar202318.03
Mar202222.34
Mar2021159.31
Mar20207.95

How is EV/Core EBITDA of ORCHID PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2024 36.42
102.00
Mar2023 18.03
-19.29
Mar2022 22.34
-85.98
Mar2021 159.31
1,903.90
Mar2020 7.95 -

Other Financial Ratios of ORCHID PHARMA


Compare EV/Core EBITDA ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹4,159.7 Cr -2.7% 5.6% -26.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,314.0 Cr -0.4% 5.7% 20.2% Stock Analytics
DIVIS LABORATORIES ₹162,809.0 Cr 1.7% 6.2% 52.9% Stock Analytics
CIPLA ₹124,627.0 Cr -0.7% 7% 8.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹111,127.0 Cr -1.6% 1.5% 21.1% Stock Analytics
DR REDDYS LABORATORIES ₹97,839.9 Cr -2.3% 2.5% -6% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

-2.7%

5.6%

-26.9%

SENSEX

2%

4.1%

9.6%


You may also like the below Video Courses